Experience

Sangha Capital SA

• Switzerland
• Investment Management
• 1 - 100 Employee

• Partner

  • Jan 2021 - 3 years

  Luxembourg, Luxembourg INVESTING IN TECHNOLOGY START-UPS THAT SOLVE THE UNITED NATION’S SUSTAINABLE DEVELOPMENT GOALS.



Integra Therapeutics

• Spain
• Biotechnology Research
• 1 - 100 Employee

• Director

  • 2022 - 1 year

  Barcelona, Catalonia, Spain Biotech company that is creating next-generation gene writing tools to boost the efficiency and safety of advanced therapies.



Minoryx Therapeutics

• Spain
• Biotechnology
• 1 - 100 Employee

• Director

  • 2022 - 1 year

  Barcelona, Catalonia, Spain Clinical-stage biotech company focused on the discovery and development of novel therapies for severe, orphan genetic diseases of the central nervous system (CNS) with high unmet medical need.



Tyris tx

• Spain
• Biotechnology
• 1 - 100 Employee

• Founder & Director

  • 2021 - 2 years

  Valencia, Valencian Community, Spain An innovative platform that expands the scope of genetic treatments by combining unprecedented DNA optimization with non-viral delivery. Development of advanced drugs that deliver the right genes to patients who have a mutated gene that causes a rare disease or condition.



Aleta Biotherapeutics Inc

• Director

  • 2021 - 2 years

  Cambridge, Massachusetts, United States Aleta Biotherapeutics, a privately held immuno-oncology company focused on transforming cellular therapeutics to allow a broad spectrum of cancer indications to be targeted, including currently untreatable solid tumors.



Syngoi Therapeutics

• Founder & Director

  • 2021 - 2 years

  Bilbao-Bilbo, Basque Country, Spain Syngoi is a bioindustrial company producing linear synthetic DNA.



COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A

• Spain
• Investment Management
• 1 - 100 Employee

• General Partner

  • Jan 2016 - 8 years

  Madrid Area, Spain Venture capital management company aimed at promoting the most disruptive early science and its transfer to companies that offer innovative medical solutions. Its differential strategy offers investors a diversified portfolio of companies that develop therapies and produce advanced medical treatments and solutions on an industrial scale. A key element is the fact that, at the time of first contact with investors to study the participation in the fund, more than 50% of the investment… Show more Venture capital management company aimed at promoting the most disruptive early science and its transfer to companies that offer innovative medical solutions. Its differential strategy offers investors a diversified portfolio of companies that develop therapies and produce advanced medical treatments and solutions on an industrial scale. A key element is the fact that, at the time of first contact with investors to study the participation in the fund, more than 50% of the investment portfolio is already defined. This makes the investment period shorter and allows the management team to focus its efforts on the development of the company and the exit. Three funds under management: Columbus INNVIERTE Life Science (€ 41M) –April 2016–, Columbus Life Science Fund II (€ 74M) –February 2019– and Columbus Life Science Fund III (€120M) Show less



ALGENEX S.L

• Spain
• Biotechnology Research
• 1 - 100 Employee

• Member Board Of Directors

  • Sep 2019 - 4 years 4 months

  Madrid, Community of Madrid, Spain Acquired by Insud Pharma, Algenex is a biotech company focused on the development of disruptive technologies for the production of recombinant proteins using baculovirus-based expression systems.



Artax Biopharma Inc

• United States
• Biotechnology Research
• 1 - 100 Employee

• Director & Founder

  • Mar 2019 - 4 years 10 months

• CEO & Co-founder

  • Sep 2013 - Feb 2019

  Cambridge, MA Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases



Fundación Columbus

• Spain
• Hospitals and Health Care
• 1 - 100 Employee

• President & Member Board of Trustees

  • 2017 - 6 years

  Valencia, Spain



Radioterapia de Protones (Quirón)

• Founder

  • 2017 - 6 years

  Madrid, Community of Madrid, Spain Together with the QuirónSalud Hospital Group, construction of the first proton radiotherapy center in Madrid.



Vivet Therapeutics

• France
• Biotechnology Research
• 1 - 100 Employee

• Founder

  • 2016 - 7 years

  France Gene therapy development company for liver diseases.



BiOncotech Therapeutics

• Board Member & Co-founder

  • Aug 2013 - 10 years 5 months

  Valencia, Spain

• CEO & Co-founder

  • May 2010 - Aug 2013

  Valencia Area, Spain Bioncotech Therapeutics is a biopharmaceutical company focused on the development of new treatments for unmet medical needs. We are currently focused on cancer and autoimmune disorders. The company was founded in 2010 as a spin-off of the Spanish National Cancer Research Center (CNIO), one of the international leaders in cancer research, and it is based in Valencia, Madrid (Spain) and Cambridge (MA, USA)



Recovid Solutions

• Spain
• Wellness and Fitness Services

• Founder and Director

  • 2020 - 2022

  Valencia, Valencian Community, Spain RECOVID, acquired by Vitro SA, works on a permanent basis to provide an efficient and integrated response to individuals, companies, and health personnel, following the guidelines established by the health authorities and the scientific community to ensure the progressive recovery of social and occupational activity.



POLYPEPTIDE THERAPEUTIC SOLUTIONS, S.L.

• Spain
• Nanotechnology Research
• 1 - 100 Employee

• Founder & Member of Board of Directors

  • Jun 2015 - Mar 2021

  Valencian Community, Spain PTS speciallizes in the design and manufacturing of polyamino-acid based delivery systems and bring value to our delivering solutions to clinical development & commercialization of therapeutic assets. In 2021 PTS was acquired by Arcline Investment Management.



SANIFIT

• Germany

• Member Board Of Directors

  • Jun 2019 - 2021

  Palma, Balearic Islands, Spain Sanifit (acquired by Vifor Pharma) is a biopharmaceutical company focused on the development of SNF472. The company was founded in 2007 as a spin-off of the University of the Balearic Islands. SNF472 is an experimental drug for the treatment of cardiovascular diseases linked to calcification in the End Stage Renal Disease population undergoing haemodialysis.



Polimer Therapeutic Solutions (Acquired by Arcline)

• Founder and Board member

  • 2012 - 2021

  Valencia, Valencian Community, Spain Company dedicated to the production of high value-added polymers for the pharmaceutical and cosmetic industry.



Viralgen Vector Core

• Spain
• Biotechnology Research
• 200 - 300 Employee

• Member Board of Directors

  • Sep 2017 - Dec 2020

  San Sebastián, Basque Country, Spain Viralgen is a CDMO born as a joint venture between Askbio and Columbus Venture Partners, combining decades of technology and drug development experience in multiple platforms to support best-in-class service offerings to the gene therapy market.Viralgen was created in 2017 in response to the unmet need for manufacturing of gene therapies and acquired in the $4B acquisition of Askbio by Bayer Pharmaceuticals



IE Business School

• Spain
• Higher Education
• 700 & Above Employee

• Professor of Entrepreneurship

  • Aug 2013 - Jun 2015

  Madrid Area, Spain Professor of the Global Entrepreneurship in the Life Sciences MBA course


FrozenShard Games
• Spain
• Computer Games
• Co-Founder

  • Sep 2012 - Jun 2015


BioCapital Advisors

• Spain

• Partner & Co-founder

  • Feb 2011 - Mar 2015

  Madrid Area, Spain Our main objective is to give our investors access to biotech opportunities, we walk with them throughtout their investment to assure a succesful exit my mitigating risks and uncertainties the start-up company might face. Our value resides in our team, that has expertise in valuation, market analyisis, business development and science, and our network.



Restaura Biotech

• Co-Founder

  • May 2011 - Sep 2012

  Restaura Biotech focuses on the application of novel biotechnological techniques for the restoration and conservation of artistic heritage.



Spanish National Center of Oncology

• Researcher

  • Mar 2008 - Jun 2010

  Expertise in development of cancer treatments (chemotherapy, immunotherapy) and broad range of molecular biology and immunology techniques; outstanding presentation and teaching skills, project management and mentoring.



University of Michigan Medical Center

• Hospitals and Health Care
• 300 - 400 Employee

• Researcher

  • Mar 2007 - Mar 2008

  Molecular Biology, drug development, autophagy, innate immune system, siRNA therapy, oncology, HTP screening.



The University of Bonn

• Germany
• Higher Education
• 700 & Above Employee

• Researcher

  • Jun 2004 - Mar 2007

  Bonn Area, Germany